Chris Boerner, PhD - Bristol Myers Squibb

Chris Boerner, PhD

Board Chair and Chief Executive Officer

Dr. Christopher Boerner, age 53, serves as board chair for Bristol Myers Squibb since April 2024 and chief executive officer since November 2023. Prior to assuming that role, he was executive vice president, chief operating officer and chief executive officer designate since April 2023. Previously, he served as executive vice president, chief commercialization officer from August 2018 to April 2023. Dr. Boerner served as head of International Markets at Bristol Myers Squibb from September 2017 to July 2018, and as president and head of U.S. Commercial Markets from February 2015 to September 2017.

From 2010 to 2015, Dr. Boerner held leadership roles of increasing responsibility at Seattle Genetics, Inc. From 2002 to 2010, he served in marketing leadership roles at Genentech, a member of the Roche Group, focused on strategy, development and commercialization across multiple oncology products and immunology. Earlier in his career, he worked for McKinsey & Company, serving global pharmaceutical and biotechnology clients.

Dr. Boerner is a member of the Executive Committee of BIO (Biotechnology Innovation Organization) and a member of the National Council for Arts and Sciences at Washington University.